These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17127238)

  • 1. Antimicrobial resistance of respiratory pathogens isolated from pediatric patients.
    Zarakolu P; Unal S
    J Chemother; 2006 Oct; 18(5):565-6. PubMed ID: 17127238
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial resistance patterns of respiratory pathogens: a local report from Turkey.
    Zarakolu P; Soyletir G; Gur D; Unal S
    Clin Microbiol Infect; 2003 Dec; 9(12):1257-8. PubMed ID: 14686999
    [No Abstract]   [Full Text] [Related]  

  • 3. Global and local variations in antimicrobial susceptibilities and resistance development in the major respiratory pathogens.
    Alpuche C; Garau J; Lim V
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S135-8. PubMed ID: 17945468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in antibiotic resistance among respiratory tract pathogens in children in two regions near France, a high level resistance country.
    Zbinden R
    Eur J Pediatr; 2006 Jan; 165(1):1-2. PubMed ID: 16133243
    [No Abstract]   [Full Text] [Related]  

  • 5. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007.
    Morrissey I; Maher K; Williams L; Shackcloth J; Felmingham D; Reynolds R;
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii97-103. PubMed ID: 18819984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
    Balkhy HH; Memish ZA; Shibl A; Elbashier A; Osoba A
    East Mediterr Health J; 2005; 11(1-2):36-44. PubMed ID: 16532669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance. Epidemiology of resistance--respiratory tract infections.
    Thomson CJ
    J Med Microbiol; 1997 Jun; 46(6):442-5. PubMed ID: 9379469
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial activities of tosufloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella branhamella catarrhalis isolated from otolaryngological infectious diseases.
    Suzuki K; Fujisawa T; Nakashima M; Hamasaki R
    J Infect Chemother; 2005 Oct; 11(5):253-5. PubMed ID: 16258823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections.
    Varon E; Levy C; De La Rocque F; Boucherat M; Deforche D; Podglajen I; Navel M; Cohen R
    Clin Infect Dis; 2000 Aug; 31(2):477-81. PubMed ID: 10987708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates from Japanese children.
    Nishi J; Yoshinaga M; Tokuda K; Masuda K; Masuda R; Kamenosono A; Manago K; Miyata K
    Int J Antimicrob Agents; 2002 Aug; 20(2):130-5. PubMed ID: 12297362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistance patterns among respiratory pathogens at a German university children's hospital over a period of 10 years.
    Arri SJ; Fluegge K; Mueller U; Berner R
    Eur J Pediatr; 2006 Jan; 165(1):9-13. PubMed ID: 16133241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antimicrobial resistance in Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis and Streptococcus pyogenes: results of a multicentre study in Turkey.
    Gür D; Ozalp M; Sümerkan B; Kaygusuz A; Töreci K; Köksal I; Over U; Söyletir G
    Int J Antimicrob Agents; 2002 Mar; 19(3):207-11. PubMed ID: 11932143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in antibiotic resistance of respiratory tract pathogens in children in Geneva, Switzerland.
    Jaecklin T; Rohner P; Jacomo V; Schmidheiny K; Gervaix A
    Eur J Pediatr; 2006 Jan; 165(1):3-8. PubMed ID: 16133242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
    Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
    J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis isolated from adult patients with respiratory tract infections in four southern European countries. The ARISE project.
    Soriano F; Granizo JJ; Coronel P; Gimeno M; Ródenas E; Gracia M; García C; Fernández-Roblas R; Esteban J; Gadea I
    Int J Antimicrob Agents; 2004 Mar; 23(3):296-9. PubMed ID: 15164972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory tract infection: epidemiology and surveillance.
    Jacobs MR
    J Chemother; 1997 May; 9 Suppl 3():10-7. PubMed ID: 9248976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000-2001: a comparison with other beta-lactam agents.
    Jones ME; Blosser-Middleton RS; Critchley IA; Karlowsky JA; Thornsberry C; Sahm DF
    J Antimicrob Chemother; 2003 Jan; 51(1):196-9. PubMed ID: 12493818
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US.
    Karlowsky JA; Draghi DC; Thornsberry C; Jones ME; Critchley IA; Sahm DF
    Int J Antimicrob Agents; 2002 Aug; 20(2):76-85. PubMed ID: 12297355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.